Status:
UNKNOWN
Hyperspectral Imaging for Neoplasm Early Stage Detection
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Hyperspectral Imaging Data of Excreta
Eligibility:
All Genders
20+ years
Brief Summary
Background Information With the advance in cancer biology, we realize that malignant neoplasm is related with different biological patterns in metabolome and microbiota. Because of the progress in opt...
Detailed Description
Background Information With the advance in cancer biology, we realize that malignant neoplasm is related with different biological patterns in metabolome and microbiota. Because of the progress in opt...
Eligibility Criteria
Inclusion
- patients with positive stool or urine analysis
- above 20 year-old
- previous stool or urine analysis negative 8 weeks ago
Exclusion
- pregnancy
- active gastrointestinal disease one year ago
- active infection
- having surgery within a year
- underlying active gastrointestinal, urinary tract, and coagulation disease
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03483974
Start Date
August 1 2017
End Date
September 30 2018
Last Update
March 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dong-Ru Ho
Chiayi City, Taiwan, 613